North America Breast Cancer Diagnostics Market Size & Outlook
North America breast cancer diagnostics market, 2018-2030 (US$M)
Related Markets
North America breast cancer diagnostics market highlights
- The North America breast cancer diagnostics market generated a revenue of USD 2,527.7 million in 2024.
- The market is expected to grow at a CAGR of 7.3% from 2025 to 2030.
- In terms of segment, imaging was the largest revenue generating type in 2024.
- Blood Tests is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 2,527.7 million |
| Market revenue in 2030 | USD 3,843.9 million |
| Growth rate | 7.3% (CAGR from 2025 to 2030) |
| Largest segment | Imaging |
| Fastest growing segment | Blood Tests |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Imaging, Biopsy, Genomic Tests, Blood Tests |
Other key industry trends
- In terms of revenue, North America region accounted for 46.1% of the global breast cancer diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,023.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Diagnostics Market Scope
Breast Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America breast cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Imaging was the largest segment with a revenue share of 54.84% in 2024. Horizon Databook has segmented the North America breast cancer diagnostics market based on imaging, biopsy, genomic tests, blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the breast cancer diagnostics market and accounted for the largest revenue share of 46.60%. The growth can be attributed to the increasing prevalence of breast cancer and rising government initiatives to increase the screening & diagnostic rate.
For instance, according to the American Cancer Society, Breast cancer remains the most prevalent cancer among women in the U.S., excluding skin cancers, accounting for nearly 30% of all new female cancer cases annually.
In 2025, an estimated 316,950 new cases of invasive breast cancer and 59,080 cases of ductal carcinoma in situ (DCIS) will be diagnosed. Tragically, 42,170 women are expected to die from the disease. The increasing incidence of breast cancer fuels demand for advanced diagnostic technologies such as mammography, genetic testing, and AI-powered imaging. Rising awareness, government initiatives, and expanding insurance coverage further stimulate the adoption of screening programs and innovative diagnostics across North America.
Reasons to subscribe to North America breast cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America breast cancer diagnostics market databook
-
Our clientele includes a mix of breast cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America breast cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into North America breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America breast cancer diagnostics market size, by country, 2018-2030 (US$M)
North America Breast Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
